Chitosan microparticles for sustaining the topical delivery of minoxidil sulphate
暂无分享,去创建一个
Guilherme Martins Gelfuso | G. M. Gelfuso | P. S. Simão | R. Lopez | Taís Gratieri | Patrícia Sper Simão | Luís Alexandre Pedro de Freitas | Renata Fonseca Vianna Lopez | T. Gratieri | L. A. P. de Freitas
[1] J. Benoit,et al. Why and how to prepare biodegradable, monodispersed, polymeric microparticles in the field of pharmacy? , 2011, International journal of pharmaceutics.
[2] M. Schaller,et al. RU 58841-myristate--prodrug development for topical treatment of acne and androgenetic alopecia. , 2005, Die Pharmazie.
[3] J. Rundegren,et al. Minoxidil: mechanisms of action on hair growth , 2004, The British journal of dermatology.
[4] J. Bouwstra,et al. Focus on skin as a possible port of entry for solid nanoparticles and the toxicological impact. , 2010, Journal of biomedical nanotechnology.
[5] N. Weiner,et al. Transfollicular Drug Delivery , 1995, Pharmaceutical Research.
[6] P. Giunchedi,et al. Spray-dried microspheres based on methylpyrrolidinone chitosan as new carrier for nasal administration of metoclopramide. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[7] Eric Doelker,et al. Influence of the preparation method on residual solvents in biodegradable microspheres , 1996 .
[8] M. H. Santana,et al. Spray-Dried Chitosan Microspheres as a pDNA Carrier , 2006 .
[9] Robert Gurny,et al. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[10] R. Mashru,et al. Effect of chitosan crosslinking on bitterness of artemether using response surface methodology , 2008, The Journal of pharmacy and pharmacology.
[11] A. Salem,et al. Rational design, fabrication, characterization and in vitro testing of biodegradable microparticles that generate targeted and sustained transgene expression in HepG2 liver cells , 2011, Journal of drug targeting.
[12] I. Chang,et al. Transdermal delivery of mixnoxidil with block copolymer nanoparticles. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[13] M. C. Bonner,et al. Transfollicular drug delivery--is it a reality? , 2005, International journal of pharmaceutics.
[14] E. Cevher,et al. Characterization of biodegradable chitosan microspheres containing vancomycin and treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with prepared microspheres. , 2006, International journal of pharmaceutics.
[15] T. Honda,et al. A targeting approach for delivery of polymer microparticle-antibody conjugate against Vibrio parahaemolyticus-induced cytotoxicity to human intestinal epithelial cells , 2007, Journal of drug targeting.
[16] N. Waranuch,et al. Targeted transfollicular delivery of artocarpin extract from Artocarpus incisus by means of microparticles. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] W. Higuchi,et al. Analysis of data on the medicament release from ointments. , 1962, Journal of pharmaceutical sciences.
[18] A. Gribanov,et al. Polyacrylonitrile: Carbonization problems , 2008 .
[19] R. Guy,et al. Disposition of Charged Nanoparticles after Their Topical Application to the Skin , 2009, Skin Pharmacology and Physiology.
[20] Wolfgang Becker,et al. Nanoparticles and microparticles for skin drug delivery. , 2011, Advanced drug delivery reviews.
[21] R. Lopez,et al. Nitric oxide photorelease from hydrogels and from skin containing a nitro-ruthenium complex. , 2010, International journal of pharmaceutics.
[22] Claus-Michael Lehr,et al. Chitosan-coated PLGA nanoparticles for DNA/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[23] G. M. Gelfuso,et al. The effects of pH and ionic strength on topical delivery of a negatively charged porphyrin (TPPS4). , 2008, Journal of pharmaceutical sciences.
[24] S. Santoyo,et al. PLGA microparticles: possible vehicles for topical drug delivery. , 2001, International journal of pharmaceutics.
[25] M. Bienová,et al. Androgenetic alopecia and current methods of treatment. , 2005, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.
[26] J. G. Souza,et al. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[27] J. Lademann,et al. Penetration profile of microspheres in follicular targeting of terminal hair follicles. , 2004, The Journal of investigative dermatology.
[28] A. Buhl,et al. Minoxidil sulfate is the active metabolite that stimulates hair follicles. , 1990, The Journal of investigative dermatology.
[29] R. Langer,et al. Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. , 2011, Biomaterials.
[30] J. Parikh,et al. Poly(D,L-Lactide-Co-Glycolide) microspheres containing 5-fluorouracil: Optimization of process parameters , 2008, AAPS PharmSciTech.